Detection, Diagnosis & Delivery
balancing therapeutic benefit and cost effectiveness
Wednesday 21 Sept 2011 from 5:30-9 pm at the Hotel du Vin Birmingham
This Innovative Healthcare Meeting features the latest biomedical research discoveries and emerging technologies for early detection of disease and improved patient care.
Debate will focus on the challenges presented by an aging population including increased cancer incidence, the pace and costs of drug discovery and a rapidly changing healthcare system, and strategies for addressing these challenges in the West Midlands.
Scientists and clinicians are invited to discuss their business plans in free private consultations with a panel of legal, business, financial and investment experts who have offered their advice to help individuals and SMEs develop their intellectual property positions and commercialisation strategies.
Join in the discussions with leading research and business experts, hear about the latest developments in the field, obtain feedback on your plans and build new partnerships.
Charlie Craddock directs the Blood and Marrow Transplant Unit at the Queen Elizabeth Hospital, is Professor of Haemato-oncology at the University of Birmingham and founded Cure Leukaemia, and has helped build the case for the region’s investment in biomedical technologies.
Charles de Rohan, CEO of the Binding Site, a Birmingham-based specialist diagnostics company with market-leading products including Freelite® and a growing international reputation for developing innovative products for early detection of disease. Charles de Rohan previously led the Genetix Group, a cell imaging and analysis company, and held senior positions at Abbott Laboratories' Diagnostic Division.
Gordon McKenzie is the Director of Clinical Development at Michelson Diagnostics and oversees the clinical trials process showing the efficacy of high resolution Optical Coherence Tomography in disease management.
Paul Moss, head of the world class School of Cancer Sciences at the University of Birmingham, with a research focus on finding ways to engage the body’s immune system in the treatment of leukaemia and the effect of cytomegalovirus on an aging population.
David Taylor is Head of Regeneration at University Hospitals Birmingham, non-executive Director of Central Technology Belt Ltd, and chair of the Birmingham Science City’s Innovative Healthcare group.
Business plans presenters:
- Luke Alderwick (Bham) on drug discovery and screening
- Chris Coulson (UHB) on a smart robot for cochlear implantation
- Heather Duncan BCH) on “Saving Young Lives"
- Baptiste Lamarre (NPL) on biomolecular surface immobilisation
- Martin Levermore (MDTi) on the ELAROS clinical utility service
- Les Lindsay (Diabetic Boot Company) on “Pulseboot”
- Frank Neumann (Innaxon) on biopharmaceutical development
Schedule: People will gather at 5:30pm for a reception and to view posters and products. A set of short talks on this important theme for our region will begin at 6pm, followed by a lively panel discussion. Dinner will be served until around 9pm, along with plenty of time for networking.
Speakers will be interviewed beforehand to share their videotaped stories with the public and press.
Innovative Healthcare Meeting tickets are available at sciencecapital.eventbrite.com
Our events are open to all and include FREE admission for those presenting business plans.
Please sign up to our mailing list to receive information about future events.